CLINICAL_TRIALS
trial_result
· 2023-06-01
Clinical Trial Update: Oxytocin Treatment in Neonates and Infants With Prader-Willi Syndrome [Phase 3]
Summary
Phase 3 clinical trial evaluating oxytocin treatment in neonates and infants with Prader-Willi syndrome has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University Hospital, Toulouse | Conditions: Prader-Willi Syndrome | Phase 3 | Status: COMPLETED